In Latvia, men's treatment options have improved significantly this year, Prostate cancer or prostate cancer is diagnosed. In conclusion, unfortunately, it can extend the average life expectancy of people who have already spread the tumor. "The young and healthy people can not imagine how important it is for them to find themselves in such situations," said the president of the Latvian Urological Society. Pauls Stradins Clinical University Hospital Urology Physician Peter Vaganovs.
Not all men are able to eliminate prostate cancer, but today, cancer is a chronic disease and, in many cases, you can live longer with prostate cancer. Also, from the beginning of this year, the state will be able to treat the fund at all stages of prostate cancer. There is also the development of therapies that can last as long as and during treatment and provide a better quality of life than ever before.
The Centers for Disease Control and Prevention (SPCC) data center reported that 4,133 out of 8,665 registered prostate cancer patients by the end of 2017 had been reported for more than five years. If prostate cancer is found, the urologist should be in contact with all life. It is important to continue regular PSA (prostate-specific antigen) follow-up and follow the doctor's instructions to maintain progressive symptoms related to incontinence, erectile problems, urine or sperm blood, regular backache or stomach ups.
"This year, a lot of research has been done about the health of Latvian males, and the people with prostate cancer have improved the usefulness of urinalysis and provided new opportunities for diagnosis, treatment and observation, which increases expectations for favorable outcomes Explained.
According to the doctor, a man who suspects prostate cancer using the "Green Corridor" can be admitted to the hospital within 10 days of a referral. "For people who have discovered malignant tumors, recent non-invasive therapies allow them to return to their normal daily lives for a few weeks and restore their efficacy over time. However, in order for this to happen, If a person regularly conducts a PSA test and goes to a doctor for the latest hardware in the urology field this year and approves several projects for new drugs for the treatment of prostate cancer at the end of metastatic cancer, Thank you. It significantly extends the patient's average life expectancy, "says Vaganov.
Known to Latvians
Globally, nearly 20 years ago, prostate cancer is the most common malignancy in men and the second most common type of cancer in the world, according to the National Health Service (NSA). According to SPCC data, in 2017, 1,200 cases of prostate cancer were diagnosed. The first prostate cancer malignancy in 2018 was eight (407) for the first time in eight months, of which 814 (NSA data) had prostate cancer.
Prostate cancer in Europe is about 3 million people in Europe. Since diagnosis has been diagnosed, half of them have been living for more than 5 years. If an initial tumor is found, it can be discarded and relieved without recurrence of the disease for 20 to 30 years or longer. Prostate cancer should routinely be tested from age 50, even if there is no complaints that prostate cancer may not have symptoms early on.
At age 50, the GP dispatcher will perform a PSA test once every two years. Prostate cancer also affects young men. If any of your family members have received this test, you should perform a test between the ages of 40 and 45. However, prostate cancer can be cured at all stages of the disease. In addition to the support and encouragement of the medical staff, things around are also very important.